Atom Investors’s Bristol-Myers Squibb BMY Stock Holding History

Atom Investors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.55M	Buy	+124,525	New	+$7.26M	0.54%	22
2025 Q4	–	Sell	-101,509	Closed	-$4.58M	–	599
2025 Q3	$4.58M	Buy	101,509 +49,292	+94%	+$2.3M	0.35%	85
2025 Q2	$2.42M	Buy	+52,217	New	+$2.56M	0.21%	135
2024 Q3	–	Sell	-42,400	Closed	-$1.76M	–	477
2024 Q2	$1.76M	Buy	42,400 +36,849	+664%	+$1.65M	0.18%	174
2024 Q1	$301K	Sell	5,551 -18,370	-77%	-$936K	0.04%	409
2023 Q4	$1.23M	Buy	+23,921	New	+$1.26M	0.22%	158
2020 Q4	–	Sell	-5,390	Closed	-$331K	–	390
2020 Q3	$325K	Buy	+5,390	New	+$324K	0.03%	281

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atom Investors's BMY Position: Q1 2026 in Review

Atom Investors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 124,525 shares worth $7.55M. The stake represents 0.54% of the portfolio and ranks #22 among its holdings. This is a return to the name: Atom Investors previously reported a position in BMY as recently as Q3 2025.

Atom Investors first reported a position in BMY in Q3 2020 and has held it in 7 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Atom Investors held 124,525 shares of Bristol-Myers Squibb worth $7.55M as of Q1 2026.
Bristol-Myers Squibb was a new Atom Investors position in Q1 2026.
Bristol-Myers Squibb made up 0.54% of Atom Investors's portfolio in Q1 2026, its #22 holding.
Atom Investors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 7 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.